XETRA - Delayed Quote EUR
Apontis Pharma AG (APPH.DE)
11.15
-0.35
(-3.04%)
At close: April 23 at 3:01:20 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-2,900.85
-2,900.85
-12,595.52
11,019.64
3,433.37
Investing Cash Flow
-2,325.63
-2,325.63
-2,933.71
-2,679.23
-1,773.43
Financing Cash Flow
-6,134.66
-6,134.66
5,999.86
-1,835.62
20,121.49
End Cash Position
15,454.51
15,454.51
26,815.65
36,345.02
29,840.23
Capital Expenditure
-2,340.45
-2,340.45
-3,262.52
-3,277.80
-1,659.94
Issuance of Capital Stock
--
--
--
--
38,000
Issuance of Debt
--
--
6,000
--
--
Repayment of Debt
-6,000
-6,000
--
--
-12,250
Repurchase of Capital Stock
--
--
--
-1,835.62
--
Free Cash Flow
-5,241.30
-5,241.30
-15,858.04
7,741.84
1,773.43
12/31/2021 - 5/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BXT.DE BioNxt Solutions Inc.
0.2850
0.00%
B8FK.DE Biofrontera AG
2.4200
-4.35%
ZOE.DE Zoetis Inc.
133.76
+2.61%
27N0.DE CANNOVUM CANNABIS AG I
0.3150
+18.87%
H6D0.DE Haleon plc
4.5020
-1.27%
PSG.DE PharmaSGP Holding SE
24.80
+5.98%
VIA.DE Viatris Inc.
6.94
+3.99%
HIGH.DE Cantourage Group SE
5.18
+8.60%
DMP.DE Dermapharm Holding SE
37.75
+3.14%
2HQ.DE Tilray Brands, Inc.
0.4041
-3.05%